Leukocidal toxins of staphylococci

Zentralblatt fur Bakteriologie

Volumn 289, Issue 2, 1999, Pages 185-201

  Szmigielski, S ^b   Prevost G ^b   Monteil, H ^b   Colin, D A ^b   Jeljaszewicz, J ^a  

^a NATIONAL INSTITUTE OF HYGIENE   (Poland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2442721428     PISSN: 09348840     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0934-8840(99)80105-4     Document Type: Article

References (40)

1. Adlam, C., P. D. Ward, and W. H. Turner: Effect of immunisation with highly purified Panton-Valentine leukocidin and delta-toxin on staphylococcal mastitis in rabbits. J. Comp. Pathol. 90 (1980) 265-274
2. Colin, D. A., I. Mazurier, S. Sire, and V. Finck-Barbançon: Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membrances: sequential binding and subsequent activation. Infect. Immun. 62 (1994) 3184-3188
3. Cooney, J., Z. Kienle, T. J. Foster, and P. W. O'Toole: The gamma haemolysin locus of Staphylococcus aureus comprises three linked genes two of which are identical to the genes for F and S components of leukocidin. Infect. Immun. 61 (1993) 768-771
4. Couppié, P. and G. Prévost: Les leucotoxines staphylococciques. Ann. Dermatol. Venerol. 124 (1997) 328-338
5. Cribier, B., G. Prévost, P. Couppié, V. Finck-Barbançon, E. Grossbans, and Y. Piemont: Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? Clin. Lab. Invest. 185 (1997) 175-180
6. Finck-Barbançon, V., G. Duportail, O. Meunier, and D. A. Colin: Pore formation by a two-component leukocidin from Staphylococcus aureus within the membrane of human polymorphonuclear leukocytes. Biochim. Biophys. Acta 1182 (1993) 275-282
7. Finck-Barbançon, V., G. Prévost, and Y. Piémont: Improved purification of leukocidin from Staphylococcus aureus and toxin distribution among hospital strains. Res. Microbiol. 142 (1991) 75-85
8. Gladstone, G. P., S. Mudd, H. D. Hochstein, and N. A. Lenhart: The assay of antistaphylococcal leukocidal components (F and S) in human serum. Brit. J. Exp. Path. 43 (1962) 295-306
9. Gladstone, G. P. and W. E. Van Heynigen: Staphylococcus leukocidin. Brit. J. Exp. Path. 38 (1957) 123-137
10. Grójec, P.: Isolation, purification and biological properties of staphylococcal leukocidin. Ph.D. Thesis, National Institute of Hygiene, Warsaw, Poland, 1977
11. Grójec, P.: Distribution of 131-I-labelled staphylococcal leukocidin in mouse organs. Med. Dośw. Mikrobiol. 31 (1979) 209-218
12. Grójec, P.: Isolation and purification of staphylococcal leukocidin. Med. Dośw. Mikrobiol. 32 (1980) 145-156
13. Grójec, P. and J. Jeljaszewicz: Effects of staphylococcal leukocidin on mouse leukocyte system. Zbl. Bakt. Hyg. I. Abt. Orig. A 250 (1981) 446-457
14. Grójec, P. and J. Jeljaszewicz: Staphylococcal leukocidin, Panton-Valentine type. J. Toxicol. Toxin Rev. 4 (1985) 133-139
15. Jeljaszewicz, J., S. Szmigielski, and P. Grójec: Reaction of rabbit and murine leukocyte system to staphylococcal leukocidin. p. 639-656. In: Staphylococci and Staphylococcal Diseaes (J. Jeljaszewicz ed.), G. Fischer Verlag, Stuttgart, New York, 1976
16. Kato, I. and M. Noda: ADP-ribosylation of cell-membrane proteins by staphylococcal alpha-toxin and leukocidin in rabbit erthrocytes and polymorphonuclear leukocytes. FEMS Lett. 255 (1989) 59-62
17. König, B., M. Köller, G. Prévost, Y. Piémont, J. E. Alouf, A. Schreiner, and W. König: Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin and erythrogenic toxin A): generation of interleukin-8. Infect. Immun. 62 (1994) 4831-4837
18. König, B., G. Prévost, Y. Piémont, and W. König: Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J. Infect. Dis. 171 (1995) 607-613
19. König, B., G. Prévost, and W. König: Composition of staphylococcal bicomponent toxins determines pathophysiologic reactions. J. Med. Microbiol. 46 (1997) 479-485
20. Loeffler, D. A., K. A. Schat, and N. L. Norcross: Use of 51-Cr releaase to measure the cytotoxic effects of staphylococcal leukocidin and toxin neutralisation on bovine leukocytes. J. Clin. Microbiol. 23 (1996) 416-420
21. Meunier, O., A. Falkenrodt, H. Monteil, and D. A. Colin: Application of flow cytometry in toxicology: pathophysiology of human polymorphonuclear leukocytes damaged by a pore-forming toxin from Staphylococcus aureus. Cytometry 21 (1995) 241-247
22. Młynarczyk, A., G. Młynarczyk, and J. Jeljaszewicz: The genome of Staphylococcus aureus: a review. Zbl. Bakt. 287 (1998) 277-314
23. Morinaga, N., M. Nagamori, and I. Kato: Changes in binding of staphylococcal leukocidin to HL-60 cells during differentiation induced by dimethylsulfoxide. Infect. Immun. 56 (1988) 2479-2483
24. Noda, M., T. Hirayama, F. Madsuda, and I. Kato: An early effect of the S component of staphylococcal leukocidin on methylation of phospholipid in various leukocytes. Infect. Immun. 50 (1985) 142-145
25. Noda, M., I. Kato, T. Hirayama, and F. Madsuda: Fixation and inactivation of staphylococcal leukocidin by phosphatydilcholine and ganglioside G-M1 in rabbit polymorphonuclear leukocytes. Infect. Immun. 29 (1980) 678-684
26. Noda, M., I. Kato, T. Hirayama, and F. Madsuda: Mode of action of staphylococcal leukocidin: effects of the S and F components on the activities of enzyme associated enzymes of rabbit polymorphonuclear leukocytes. Infect. Immun. 35 (1992) 38-45
27. Noda, M. and I. Kato: Mode of action of staphylococcal leukocidin: relationship between binding of 125-I-labelled S and F components of leukocidin to rabbit polymorphonuclear leukocytes and leukocidin activity. Infect. Immun. 34 (1981) 362-367
28. Noda, M. and I. Kato: Leukocidal toxins, p. 243-251. In: Alouf, J. E. and J. E. Freer (Eds.) Source Book of Bacterial Toxins. Academic Press Ltd., New York - London, 1990
29. Pfanneberg, T., H. Blobel und W. Schaeg: Zytotoxische Wirkungen eines Leukozidins von Staphylococcus aureus. Zbl. Bakt. Hyg. I. Abt. Orig. 223 (1975) 147-152
30. Prévost, G., B. Cribier, P. Couppié, P. Petiau, G. Supersac, V. Finck-Barbançon, H. Monteil, and Y. Piemont: Panton-Valentine leukocidin and gamma-haemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect. Immun. 63 (1995) 4121-4129
31. Prévost, G., P. Couppié, P. Prévost, S. Gayet, P. Petiau, B. Cribier, H. Monteil, and Y Piemont: Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J. Med. Microbiol. 42 (1995) 237-245
32. Prévost, G., G. Supersac, and D. A. Colin: The new family of leukotoxins from Staphylococcus aureus: structural and biochemical properties, p. 284-293. In: Bacterial Protein Toxins (J. H. Freer ed.) Zbl. Bakt. suppl. 24, G. Fischer Verlag, Stuttgart, 1994
33. 2+ channels in the membrane of human polymorphonuclear neutrophils. J. Membr. Biol. 162 (1998) 209-216
34. Szmigielski, S., J. Jeljaszewicz, and C. Zak: Leukocyte system of rabbits receiving repeated injections of staphylococcal leukocidin. Path. Microbiol. 31 (1968) 328-336
35. Szmigielski, S. and J. Jeljaszewicz: Stimulatory effect of staphylococcal leukocidin on granulopoiesis disturbed by cytostatic agents. Cancer Lett. 1 (1976) 299-303
36. Szmigielski, S., J. Jeljaszewicz, J. Wilczyński, and J. Korbecki: Reaction of rabbit leukocytes to staphylococcal (Panton-Valentine) leukocidin in vivo. J. Path. Bact. 91 (1966) 599-604
37. Szmigielski, S., E. Sobiszewska, A. K. Siwicki, J. Jeljaszewicz, and G. Prévost: Effects of purified staphylococcal leukocidal toxins on isolated blood polymorphonuclear leukocytes and peritoneal macrophages in vitro. Med. Dośw. Mikrobiol. (1999) in press
38. Ward, P. D. and W. H. Turner: Identification of staphylococcal Panton-Valentine leukocidin as a potent dermonecrotic toxin. Infect. Immun. 27 (1980) 393-397
39. Weiss, S. J.: Tissue destruction by neutrophils. New Engl. J. Med. 320 (1989) 365-376
40. Woodin, A. M.: Purification of the two components of leukocidin from Staphylococcus aureus. Biochem. J. 75 (1960) 158-165